Application 212515
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212515-001 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | AB2 | 2023-06-06 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | AB2 | 2023-06-06 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | AB2 | 2023-06-06 | 3f0d92c62455… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212515-001 | AB2 | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212515-001 | AB2 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212515-001 | AB2 | 1 | 3f0d92c62455… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals, Inc. | 2c4108c6-9014-4bd8-e063-6294a90a88fa | 2025-07-08 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| tadalafil | TADALAFIL | Asclemed USA, Inc. | fa547e3d-455a-4926-9fd9-349930898502 | 2025-06-25 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Bryant Ranch Prepack | 716c586d-e524-4f3e-ab1d-7ef9184169d9 | 2025-06-02 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| tadalafil | TADALAFIL | Proficient Rx LP | 7976c4ec-ecc4-4a49-a4fe-f990aece2d3c | 2025-06-01 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | 351de7c2-98bf-7c88-e063-6294a90ad811 | 2025-05-21 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | 34684fe8-9bf3-47fd-e063-6394a90ac80f | 2025-05-14 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | 31f5dc06-50f8-47cf-e063-6294a90ad5fb | 2025-04-14 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | e899da81-a28e-4a7e-a0e6-ed6d557c0bcd | 2025-04-08 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 828f0ee1-b9fc-4743-9394-fc086bcf5345 | 2025-04-08 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Bryant Ranch Prepack | 24b82a6a-1b7e-42e6-b29b-41d4ee4d525f | 2025-04-03 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Solco Healthcare US, LLC | 491cb72b-71f2-4df9-99f8-c02d93500103 | 2025-03-31 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | 0a9cf85a-c17d-6890-e063-6394a90a93e9 | 2025-03-04 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Teva Pharmaceuticals, Inc. | 3ad14d63-42e7-493f-b56c-e02a4fd139f7 | 2025-03-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals, Inc. | 2eae8756-5c7f-2545-e063-6294a90a6d52 | 2025-02-21 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | cf35291b-b05b-1182-e053-2995a90a8dee | 2025-02-10 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | bce03930-14c5-401f-ad17-06b7709983bc | 2025-02-07 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Alembic Pharmaceuticals Inc. | abcb2cda-9b3f-45f6-ad5f-c2370b0dd114 | 2025-02-03 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals,Inc. | 0b75f746-866e-3a5b-e063-6294a90a5e02 | 2025-01-03 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals, Inc. | 2ad52dff-9fcd-041f-e063-6394a90afcef | 2025-01-03 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals,Inc. | 2a4666e1-4151-f540-e063-6394a90aed0b | 2024-12-27 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.